PRA Health Sciences, Inc.
PRAH
PRAH was delisted on the 30th of June, 2021.
300 hedge funds and large institutions have $5.25B invested in PRA Health Sciences, Inc. in 2020 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 97 increasing their positions, 131 reducing their positions, and 75 closing their positions.
117% more call options, than puts
Call options by funds: $8.28M | Put options by funds: $3.81M
0.65% less ownership
Funds ownership: 100.13% → 99.49% (-0.65%)
13% less funds holding
Funds holding: 345 → 300 (-45)
25% less capital invested
Capital invested by funds: $7.04B → $5.25B (-$1.79B)
26% less repeat investments, than reductions
Existing positions increased: 97 | Existing positions reduced: 131
55% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 75
83% less funds holding in top 10
Funds holding in top 10: 6 → 1 (-5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$95.9M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
+$71.1M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$47.4M |
| 4 |
NIPH
NN Investment Partners Holdings
The Hague,
Netherlands
|
+$26.4M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
+$16.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCM
Glenview Capital Management
New York
|
-$28.1M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$21.7M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$17.8M |
| 4 |
SO
STRS Ohio
Columbus,
Ohio
|
-$17.3M |
| 5 |
BlackRock
New York
|
-$16.6M |
PRAH Hedge Fund Activity: Q1 2020 in Review
300 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in PRA Health Sciences, Inc. (PRAH) for Q1 2020, worth a combined $5.25B — down 25% from $7.04B a quarter earlier.
Sellers outnumbered buyers: 75 funds closed out of PRAH and 34 opened new positions — a net loss of 41 holders — while 131 trimmed existing stakes and 97 added.
The largest buyer was Massachusetts Financial Services, adding an estimated $95.9M. The largest seller was Glenview Capital Management, exiting entirely with an estimated $28.1M sold.
- 300 institutional investors held PRA Health Sciences, Inc. (PRAH) as of Q1 2020, down from 345 in Q4 2019.
- Funds reported $5.25B of PRA Health Sciences, Inc. stock for Q1 2020, down 25% quarter-over-quarter.
- 34 funds opened new PRA Health Sciences, Inc. positions in Q1 2020 and 75 closed out, a net change of -41 holders.
- The largest PRA Health Sciences, Inc. buyer in Q1 2020 was Massachusetts Financial Services, an estimated $95.9M added.
- The largest PRA Health Sciences, Inc. seller in Q1 2020 was Glenview Capital Management, an estimated $28.1M sold.
Based on aggregated 13F filings for Q1 2020.